Company intelligence / Profile preview
Sauvie Inc.
Short Hills, New Jersey, United Statessauvieinc.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Sauvie Inc. is developing transformational immuno-oncology therapies using its proprietary CAM-V™ single-domain antibody platform and a nanobody-based bispecific NK cell engager targeting HER2+ cancers. The company has entered into an exclusive worldwide license agreement with Rutgers University for this technology. Early-stage research has demonstrated high affinity and specificity for the anti-HER2 VHH, as well as promising preclinical data for their BiKE (bispecific killer engager) approach.[1][3] No human clinical results have been reported publicly.
- Therapeutic areas
- Oncology
- Modalities
- Single-domain antibodiesBispecific NK cell engagers
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Rutgers University – exclusive worldwide license agreement for bi-specific NK cell engager technology in oncology
Beyond the preview
Go deeper on Sauvie Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sauvie Inc..